Showing results (181-190 of 322) with videos related to
Sort By:
Pageof 33
Journal of Medical Internet Research|March 5, 2011
A theory-based video messaging mobile phone intervention for smoking cessation: randomized controlled trialRobyn Whittaker, Enid Dorey, Dale Bramley, et al.Stroke|April 27, 2012
Effects of blood pressure lowering on intracranial and extracranial bleeding in patients on antithrombotic therapy: the PROGRESS trialHisatomi Arima, Craig Anderson, Teruo Omae, et al.Plos Medicine|May 27, 2005
Rethinking the "diseases of affluence" paradigm: global patterns of nutritional risks in relation to economic developmentMajid Ezzati, Stephen Vander Hoorn, Carlene M M Lawes, et al.Hypertension (Dallas, Tex. : 1979)|May 17, 2016
Comparative Cost-Effectiveness of Conservative or Intensive Blood Pressure Treatment Guidelines in Adults Aged 35-74 Years: The Cardiovascular Disease Policy ModelNathalie Moise, Chen Huang, Anthony Rodgers, et al.Diabetes Care|July 27, 2016
Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 DiabetesKamel Mohammedi, Mark Woodward, Yoichiro Hirakawa, et al.Nutrition & Diabetes|January 19, 2018
Associations between body mass index and the risk of renal events in patients with type 2 diabetesKamel Mohammedi, John Chalmers, William Herrington, et al.Plos Medicine|August 29, 2012
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysisJicheng Lv, Bruce Neal, Parya Ehteshami, et al.Lancet (London, England)|March 7, 2003
Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease riskChristopher J L Murray, Jeremy A Lauer, Raymond C W Hutubessy, et al.Addiction (Abingdon, England)|June 10, 2010
Pre-cessation nicotine replacement therapy: pragmatic randomized trialChris Bullen, Colin Howe, Ruey-Bin Lin, et al.Journal of Hypertension|April 22, 2021
Combination blood pressure lowering in the presence or absence of background statin and aspirin therapy: a combined analysis of PROGRESS and ADVANCE TrialsNelson Wang, Katie Harris, John Chalmers, et al.Pageof 33